Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F5ZZP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,114
Award facts
- Contract value 100% obligated
- $25,113.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,113.65 by the Defense Logistics Agency's Medical Supply Chain on June 24, 2025. The order is for Soliris (complement inhibitor) 300 mg/30 mL vials and represents a firm fixed-price delivery under the company's existing Indefinite Delivery Contract with DLA. No set-aside designation was utilized for this award. The contract is scheduled for ultimate completion by July 16, 2025, with performance taking place at the awardee's facility in Park Ridge, Illinois.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company holds a significant single-award IDC with DLA valued at $499,999,999 through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has consistently leveraged its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of pharmaceutical product deliveries covering prescription medications, biologics, and medical consumables across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DX25F5ZZP?
SPE2DX25F5ZZP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 24, 2025.
How much is contract SPE2DX25F5ZZP worth?
The government has obligated $25,114 on SPE2DX25F5ZZP.
Is contract SPE2DX25F5ZZP an order under another contract?
Yes. SPE2DX25F5ZZP is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZZP competed?
The extent of competition for SPE2DX25F5ZZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award